Files

Abstract

Disclosed are methods of treating an acute myeloid leukemia patient of cytogenetic subgroups having increased histone deacetylase recruitment by administering a histone deacetylase inhibitor to the patient.

Details

Actions

PDF

from
to
Export
Download Full History